期刊文献+

Expression of cell cycle regulator p57^(kip2), cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: An immunohistochemical study 被引量:14

Expression of cell cycle regulator p57^(kip2), cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: An immunohistochemical study
下载PDF
导出
摘要 AIM: To investigate the effects of p57^kip2, cyclinE protein and proliferating cell nuclear antigen (PCNA) on occurrence and progression of human pancreatic cancer. METHODS: The expression of p57^kip2, cyclinE protein and PCNA in tumor tissues and adjacent tissues from 32 patients with pancreatic cancer was detected by SP immunohistochemical technique. RESULTS: The positive expression rate of p57^kip2 protein in tumor tissues was 46.9%, which was lower than that in adjacent pancreatic tissues (χ^2 = 5.317, P〈0.05). p57^kip2 protein positive expression remarkably correlated with tumor cell differentiation (P〈0.05), but not with lymph node metastasis (P〉0.05). The positive expression rate of cyclinE protein in tumor tissues was 68.8%, which was higher than that in adjacent pancreatic tissues (χ^2 = 4.063, P〈0.05). CyclinE protein positive expression significantly correlated with tumor cell differentiation and lymph node metastasis (P〈0.05). The positive expression rate of PCNA in the tumor tissues was 71.9%, which was higher than that in adjacent pancreatic tissues (χ^2 = 5.189, P〈0.05). PCNA positive expression remarkably correlated with tumor cell differentiation and lymph node metastasis (P〈0.05). CONCLUSION: The decreased expression of p57^kip2 and/or overexpression of cyclinE protein and PCNA may contribute to the occurrence and progression of pancreatic cancer. p57^kip2, cyclinE protein, and PCNA play an important role in occurrence and progression of pancreatic cancer. AIM: To investigate the effects of p57kip2, cyclinE protein and proliferating cell nuclear antigen (PCNA) on occurrence and progression of human pancreatic cancer.METHODS: The expression of p57kip2, cyclinE protein and PCNA in tumor tissues and adjacent tissues from 32patients with pancreatic cancer was detected by SP immunohistochemical technique.RESULTS: The positive expression rate of p57kip2 protein in tumor tissues was 46.9%, which was lower than that in adjacent pancreatic tissues (x2 = 5.317, P<0.05). P57kip2protein positive expression remarkably correlated with tumor cell differentiation (P<0.05), but not with lymph node metastasis (P>0.05). The positive expression rate of cyclinE protein in tumor tissues was 68.8%, which was higher than that in adjacent pancreatic tissues (x2 = 4.063,P<0.05). CyclinE protein positive expression significantly correlated with tumor cell differentiation and lymph node metastasis (P<0.05). The positive expression rate of PCNA in the tumor tissues was 71.9%, which was higher than that in adjacent pancreatic tissues (x2 = 5.189, P<0.05).PCNA positive expression remarkably correlated with tumor cell differentiation and lymph node metastasis (P<0.05).CONCLUSION: The decreased expression of p57kip2 and/or overexpression of cyclinE protein and PCNA may contribute to the occurrence and progression of pancreatic cancer.p57kip2, cyclinE protein, and PCNA play an important role in occurrence and progression of pancreatic cancer.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第32期5057-5060,共4页 世界胃肠病学杂志(英文版)
关键词 P57^KIP2 CYCLINE PCNA Human pancreatic cancer 细胞周期 基因表达 p57^kip2 细胞核抗原 胰腺癌 免疫组织化学
  • 相关文献

参考文献29

  • 1Clurman BE, Roberts JM. Cell cycle and cancer. J Natl Cancer Inst 1995; 87:1499-1504.
  • 2Grana X, Reddy EP. Cell cycle control in mammalian cells:role of cyclins, cyclin dependent kinase(CDKs), growth suppressor and cyclin dependent kinase inhibitors(CDKIs).Oncogene 1995; 11:211-219.
  • 3Sherr CJ. G1 phase progression :cyclin on cue. Cell 1994; 79:551-555.
  • 4Sherr CJ. Cancer cell cycles. Science 1996; 274:1672-1677.
  • 5Kamb A. Cell-cycle regulators and cancer. Trends Genet 1995;11:136-140.
  • 6Hunter T, Pines J. Cyclins and cancer Ⅱ: CyclinD and CDK inhibitors come of age. Cell 1994; 79:573-582.
  • 7Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K,Tavtigian SV, Stockent E, Day RS 3rd, Johon BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264:436-440.
  • 8Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ. p57^KIP2 a structurally distinct member of the p2KIP1 cdk inhibitor family ,is a candidate tumor suppressor gene. Genes Dev 1995; 9:650-662.
  • 9Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee MH, Gerald WL, Massague J, Weissman BE, Cordon-Cardo C. Cyclin-dependent kinase inhibitor p57^KIP2 in soft tissue sarcomas and wilms tumor. Cancer Res 1996; 56:1219-1221.
  • 10Lee MH, Reynisdottir I, Massague J. cloning of p57^KIP2, acyclin dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995; 9:639-649.

同被引文献39

引证文献14

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部